ING Groep NV boosted its stake in shares of UnitedHealth Group Inc (NYSE:UNH) by 48.0% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 301,997 shares of the healthcare conglomerate’s stock after buying an additional 97,994 shares during the period. UnitedHealth Group comprises 1.1% of ING Groep NV’s investment portfolio, making the stock its 20th largest holding. ING Groep NV’s holdings in UnitedHealth Group were worth $59,146,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other hedge funds and other institutional investors also recently bought and sold shares of the business. D.A. Davidson & CO. boosted its position in UnitedHealth Group by 2.5% during the third quarter. D.A. Davidson & CO. now owns 72,007 shares of the healthcare conglomerate’s stock worth $14,102,000 after purchasing an additional 1,749 shares during the period. First Interstate Bank boosted its position in UnitedHealth Group by 4.4% during the third quarter. First Interstate Bank now owns 50,976 shares of the healthcare conglomerate’s stock worth $9,984,000 after purchasing an additional 2,128 shares during the period. Wasatch Advisors Inc. bought a new stake in UnitedHealth Group during the third quarter worth approximately $228,000. Brighton Jones LLC boosted its position in UnitedHealth Group by 320.7% during the third quarter. Brighton Jones LLC now owns 12,357 shares of the healthcare conglomerate’s stock worth $2,420,000 after purchasing an additional 9,420 shares during the period. Finally, Renaissance Group LLC bought a new stake in UnitedHealth Group during the third quarter worth approximately $33,917,000. Hedge funds and other institutional investors own 86.00% of the company’s stock.
UnitedHealth Group Inc (NYSE:UNH) traded up $2.14 during midday trading on Wednesday, hitting $228.78. The stock had a trading volume of 2,880,000 shares, compared to its average volume of 4,300,000. The firm has a market capitalization of $221,700.00, a price-to-earnings ratio of 24.08, a P/E/G ratio of 1.32 and a beta of 0.70. The company has a debt-to-equity ratio of 0.58, a quick ratio of 0.70 and a current ratio of 0.73. UnitedHealth Group Inc has a 52 week low of $156.49 and a 52 week high of $250.79.
UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, January 16th. The healthcare conglomerate reported $2.59 EPS for the quarter, topping the Zacks’ consensus estimate of $2.50 by $0.09. UnitedHealth Group had a return on equity of 21.29% and a net margin of 5.25%. The company had revenue of $52.06 billion for the quarter, compared to analyst estimates of $51.57 billion. During the same quarter last year, the firm posted $2.11 earnings per share. UnitedHealth Group’s revenue was up 9.5% compared to the same quarter last year. analysts anticipate that UnitedHealth Group Inc will post 12.51 EPS for the current fiscal year.
The company also recently announced a quarterly dividend, which will be paid on Tuesday, March 20th. Investors of record on Friday, March 9th will be given a $0.75 dividend. This represents a $3.00 dividend on an annualized basis and a yield of 1.31%. UnitedHealth Group’s dividend payout ratio is presently 31.58%.
UNH has been the subject of a number of research analyst reports. Credit Suisse Group reiterated a “buy” rating on shares of UnitedHealth Group in a report on Wednesday, December 27th. Cantor Fitzgerald upped their price target on UnitedHealth Group to $225.00 and gave the stock an “overweight” rating in a report on Wednesday, October 18th. Evercore ISI restated an “outperform” rating and issued a $255.00 target price (up from $235.00) on shares of UnitedHealth Group in a research note on Friday, January 12th. Wells Fargo & Co restated an “outperform” rating and issued a $245.00 target price (up from $230.00) on shares of UnitedHealth Group in a research note on Wednesday, November 29th. Finally, Zacks Investment Research upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $267.00 target price for the company in a research note on Saturday, January 20th. Two research analysts have rated the stock with a hold rating and twenty-six have assigned a buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and a consensus price target of $243.22.
In related news, Director Gail R. Wilensky sold 5,600 shares of UnitedHealth Group stock in a transaction that occurred on Wednesday, November 29th. The stock was sold at an average price of $223.31, for a total value of $1,250,536.00. Following the sale, the director now owns 61,137 shares of the company’s stock, valued at approximately $13,652,503.47. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Michele J. Hooper sold 10,000 shares of UnitedHealth Group stock in a transaction that occurred on Wednesday, January 31st. The shares were sold at an average price of $237.76, for a total value of $2,377,600.00. Following the completion of the sale, the director now directly owns 37,284 shares in the company, valued at approximately $8,864,643.84. The disclosure for this sale can be found here. In the last three months, insiders sold 53,396 shares of company stock worth $12,262,067. 0.89% of the stock is owned by insiders.
TRADEMARK VIOLATION WARNING: “ING Groep NV Has $59.15 Million Holdings in UnitedHealth Group Inc (NYSE:UNH)” was published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this piece of content on another domain, it was illegally copied and republished in violation of international copyright & trademark law. The legal version of this piece of content can be read at https://www.dispatchtribunal.com/2018/02/14/unitedhealth-group-inc-unh-shares-bought-by-ing-groep-nv.html.
About UnitedHealth Group
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.